Taken together, these observations suggest that CD31, CD34, Sirt1 mRNAs, miR-126-3p, miR-34a [93] and the S120fraction of Sirt1 [94] could be used as molecular biomarkers for a better diagnosis of COPD. The gene discussed is SIRT1; the disease is chronic obstructive pulmonary disease.